Synthesis and anticancer activities of some new coumarin derivatives including the triazole ring and their in silico molecular docking studies

The synthesis, docking study, and investigation of the anticancer activities of some coumarin derivatives containing the triazole ring are reported in this study. The newly synthesized compounds were screened for their in vitro anticancer activity against the cell lines CRL5807 (human bronchioalveolar carcinoma), CRL5826 (human squamous cell carcinoma), MDA‐MB231 (human breast cancer cells), HTB177 (human lung cancer), PC‐3 (human prostate adenocarcinoma), PANC‐1 (human pancreatic cancer cells), used as cancer cells, and CCD34Lu (normal human lung fibroblasts), used as a healthy cell line. Cytotoxicity effects of the samples were determined by the MTT (3‐(4,5‐dimethyl‐2‐thiazolyl)‐2,5‐diphenyl‐2H‐tetrazolium bromide) assay. In silico studies were also performed to explore the binding interactions of the molecules. A series of coumarin derivatives containing the triazole ring was synthesized and investigated for their anticancer activities, using six cancer cell lines and one healthy cell line. The docking study suggests that the compounds can be determined as potential leads against cancer with significant interactions with human topoisomerase IIα.